Epoetin Beta-Methoxy Polyethylene Glycol (Hemax (4000 iu)) is an erythropoiesis-stimulating agent, prescribed for anemia in people with chronic kidney failure. The information provided on this ...

Adult- IV- Initial dose: The recommended dose is 0.6 mcg/kg. Caution should be exercised in patients with history of heart disease, high blood pressure, cancer, seizures, blood cell disorder ...

All patients received subcutaneous epoetin once weekly at an initial dose of 25-100 IU/kg. Dose adjustments were permitted every four weeks as needed to achieve the target hemoglobin level ...

The latest 4,000 IU dose provides the ease of a single dosage for many patients. Last December, Advate received FDA approval as a regular prophylaxis to curtail the incidence of bleeding for ...

The recommendations are based on evidence from trials in which epoetin was administered t.i.w. subcutaneously. The recommended starting dose is therefore 150 IU/kg t.i.w. for a minimum of 4 weeks ...

These patients had a variety of solid tumors requiring chemotherapy or radiation and were given epoetin alfa either 40,000 IU once weekly or 10,000 IU 3 times weekly. Two commercial preparations ...

In the per-protocol analysis, mean baseline epoetin dose increased from 63.54 IU/kg/week to 64.96 IU/kg/week during weeks 13–25 in the weekly cohort (+1.42 IU/kg/week [+2%]), and from 33.66 IU ...

Using median Hb as a divider, the low Hb group (mean Hb 10.1 g/dL) received a mean 6206.2 IU/week of epoetin, whereas the high Hb group (mean Hb 11.7 g/dL) received a mean 2732.1 IU/week.

ESAs are used with a target hemoglobin level above 10 g/dl (mean dose of epoetin α in our center is 4430 IU/week). Given the potential for side effects, we do not routinely use ESA doses greater than ...

It was planned that all patients would receive 16 doses of 30 000 IU epoetin beta (NeoRecormon, Roche AB, Sweden) by subcutaneous injection once weekly. 16 Concomitantly, on the same day iron ...